Pharmacy Is Right For Me
FEBRUARY 22, 2024
There is a common misconception that all community pharmacies are alike, and that most of what community pharmacists do is count pills. This could not be further from the truth and Dr. Mohanad Znbaqa’s story will demonstrate just how versatile a career practicing in a community pharmacy can be! Expanding Horizons: A Pharmacist’s Journey in Ambulatory Care Dr.
Pharmacy Times
FEBRUARY 19, 2024
The full scope of pharmacy practice offers a transformative approach to health care delivery, promising improved patient outcomes, greater access to care, and efficient utilization of health care resources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 20, 2024
Mental health challenges in the United States were exacerbated by the COVID-19 pandemic, and pharmacists are poised to help pick up the pieces.
Drug Store News
FEBRUARY 21, 2024
Recent data from YouGov Profiles reveals that nearly half of Americans (47%) buy OTC drugs as required rather than stocking up, followed by 39% who keep a stock of medications but buy others when necessary.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
FEBRUARY 21, 2024
How much longer can independent pharmacists survive with the current method of reimbursement?
PharmaVoice
FEBRUARY 21, 2024
The first-of-its-kind TIL therapy for solid tumors developed by Iovance Biotherapeutics won FDA approval last week.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 23, 2024
Hospitals, pharmacies, and other health care providers are getting stuck in an insurance processing logjam after UnitedHealth Group disclosed a cyberattack within a recently acquired subsidiary that serves as a central hub for payments across the industry. The cyberattack and subsequent system outage within UnitedHealth’s Change Healthcare has caught the attention of federal law enforcement agencies.
Drug Topics
FEBRUARY 23, 2024
Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.
PharmaVoice
FEBRUARY 23, 2024
Following Moderna’s COVID-19 vaccine success, therapeutics head Dr. Kyle Holen discusses scaling mRNA development to bring candidates to the finish line in oncology and more.
Pharmacy Times
FEBRUARY 19, 2024
California's Stop Dangerous Pharmacies Act aims to improve patient safety by establishing new pharmacy staffing regulations and a medication error reporting system, arising from understaffed conditions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 22, 2024
A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease. In a letter dated Tuesday about an outbreak at Manatee Bay Elementary School in Weston, located northwest of Miami and west of Fort Lauderdale, the state’s surgeon general, Joseph Ladapo, said that while it is normal policy to tell unvaccinated children to stay home during an outbrea
Drug Topics
FEBRUARY 20, 2024
Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.
PharmaVoice
FEBRUARY 20, 2024
A significant growth is predicted for both AI and IoT in healthcare. By 2030, the AI market is expected to reach $187.95 billion USD, while the IoT market is projected to climb even higher to $312.7 billion USD.
Pharmacy Times
FEBRUARY 22, 2024
Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
FEBRUARY 22, 2024
When a psychology professor in Michigan looked through his data on interpersonal conflict a decade ago, he discovered something unexpected. The study , which examined differences across cultures and age groups, seemed to show Americans got wiser as they got older. Richard Nisbett was used to research showing poorer mental skills among elderly adults, but his work found they were better at recognizing multiple perspectives, encouraging compromise, and acknowledging the limits of their own knowled
Drug Topics
FEBRUARY 23, 2024
With over 3% of the world’s population affected by chronic hepatitis B, TherVacB has the potential to address a critical unmet need for a cure.
PharmaVoice
FEBRUARY 21, 2024
A splashy IPO, first-in-class treatments and upcoming approval dates are a few reasons we’ve got our eyes on these biotechs this year.
Pharmacy Times
FEBRUARY 23, 2024
The evolution of pharmacy, as a practice and profession, is unique in that its evolution has quickened exponentially in just the past 20 years.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
FEBRUARY 22, 2024
Imagine having 15 miscarriages. Maybe you can shrug off the first one or two and keep trying to have children, to create a family. But soon every positive pregnancy test brings a sense of dread, of sad inevitability. Your body becomes your enemy.
Drug Topics
FEBRUARY 23, 2024
During a session at the Outcomes 2024 SYNC National Conference, Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed the impacts that advancements in technology have had on pharmacy.
PharmaVoice
FEBRUARY 20, 2024
While buzz builds around “off the shelf” CAR-T cell therapies, Kite is staying competitive with a shorter manufacturing turnaround and a focus on broadening applications.
Pharmacy Times
FEBRUARY 23, 2024
Investing in community relationships and health literacy are key steps pharmacists can take to improve equity.
STAT
FEBRUARY 21, 2024
Alison Sbrana was in the belly of an opera when her life changed. Down in the pit, surrounded by fellow orchestra members, she’d been straining to play her flute for half the show. As performers overhead enveloped the audience in arias, Sbrana felt like the Hulk was pulling on the tendons in the right side of her neck. “I begged anybody for meds at intermission,” she said.
Drug Topics
FEBRUARY 19, 2024
After myocardial infarction, all-cause mortality was the most frequent event, followed by heart failure, renal failure, and atrial fibrillation.
Fierce Healthcare
FEBRUARY 22, 2024
Investors continue to pour money into generative AI startups and Abridge is riding this wave as it rapidly scales its technology across U.S. health systems. | Along with the funding round, Abridge also announced an enterprise agreement with Connecticut-based Yale New Haven Health System to give thousands of clinicians access to its AI-powered clinical documentation technology.
Pharmacy Times
FEBRUARY 23, 2024
Four years after congress passed it, the Hannon Act is helping veterans get better care
STAT
FEBRUARY 21, 2024
SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of fog blanketing the San Francisco skyline. Its warmth did not reach the operating room tucked into the sprawling Parnassus Heights hospital complex. In there, the light was all cold and blue fluorescence washing over the sea of scrub caps huddled around an anesthetized young woman on a gurney.
Drug Topics
FEBRUARY 21, 2024
The novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.
Fierce Healthcare
FEBRUARY 22, 2024
Change Healthcare is mitigating a "cybersecurity issue" that began Wednesday, and details remain scant. | Change Healthcare is mitigating a "cybersecurity issue" that began Wednesday, and details remain scant.
Pharmacy Times
FEBRUARY 20, 2024
Nearly 60% of patients who regained all the weight stayed in remission at 5 years post-surgery, according to study results.
STAT
FEBRUARY 20, 2024
Groundbreaking research more than a decade ago showed that almost one-fifth of people enrolled in Medicare were being readmitted within 30 days after being discharged from the hospital, harming patients and increasing costs. That study led to a sea change in health care. The government started closely monitoring readmission rates and imposing fines on hospitals with high rates.
Drug Topics
FEBRUARY 22, 2024
On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.
pharmaphorum
FEBRUARY 23, 2024
Explore the opportunities and challenges facing rare disease therapies developers, including the impact of Rare Disease Day, FDA regulations, and cutting-edge technologies like CRISPR gene therapy.
Expert insights. Personalized for you.
130 
Let's personalize your content